Human melanoma cell line UV responses show independency of p53 function

Cell Growth and Differentiation

Volumn 10, Issue 3, 1999, Pages 163-171

  Haapajärvi, Tarja ^a   Pitkänen, Kimmo ^a   Laiho, Marikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CELL FUNCTION; DNA BINDING; DNA DAMAGE; DNA HELIX; DNA REPLICATION; EXCISION REPAIR; GENE INDUCTION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; RADIATION RESPONSE; SKIN CANCER; ULTRAVIOLET RADIATION;

BLOTTING, NORTHERN; BROMODEOXYURIDINE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOMA; MUTAGENESIS; NUCLEAR PROTEINS; NUCLEIC ACID SYNTHESIS INHIBITORS; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, MESSENGER; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 0345435175     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Paulovich, A. G., Toczyski, D. P., and Hartwell, L. H. When checkpoints fail. Cell, 88: 315-321, 1997.
2. Ziegler, A., Leffell, D. J., Kunala, S., Sharma, H. W., Gailani, M., Simon, J. A., Halperin, A. J., Baden, H. P., Shapiro, P. E., Bale, A. E., and Brash, D. E. Mutation hotspot due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl. Acad. Sci. USA, 90: 4216-4220, 1993.
3. Nakazawa, H., English, D., Randell, P. L., Nakazawa, K., Martel, N., Armstrong, B. K., and Yamasaki, H. UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc. Natl. Acad. Sci. USA, 91: 360-364, 1994.
4. Pollock, P. M., Pearson, J. V., and Hayward, N. K. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer, 15: 77-88, 1996.
5. Castellano, M., Pollock, P. M., Walters, M. K., Sparrow, L. E., Down, L. M., Gabrielli, B. G., Parsons, P. G., and Hayward, N. CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Res., 57: 4868-4875, 1997.
6. Tornaletti, S., and Pfeifer, G. P. Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science (Washington DC), 263: 1436-1438, 1994.
7. Ziegler, A., Jonason, A. S., Leffell, D. J., Simon, J. A., Sharma, H. W., Kimmelman, J., Remington, L., Jacks, T., and Brash, D. E. Sunburn and p53 in the onset of skin cancer. Nature (Lond.), 372: 773-776, 1994.
8. Ananthaswamy, H. N., Loughlin, S. M., Cox, P., Evans, R. L., Ullrich, S. E., and Kripke, M. L. Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nat. Med., 3: 510-514, 1997.
9. Hartmann, A., Blaszyk, H., Cunningham, J. S., McGovern, R. M., Schroeder, J. S., Helander, S. D., Pittelkow, M. R., Sommer, S. S., and Kovach, J. S. Overexpression and mutations of p53 in metastatic malignant melanomas. Int. J. Cancer, 67: 313-317, 1996.
10. Flœrens, V. A., Îyjord, T., Holm, R., Skrede, M., Bœrresen, A. L., Nesland, J. M., and Fœdstad, Î. TP53 allele loss, mutations and expression in malignant melanoma. Br. J. Cancer, 69: 253-259, 1994.
11. Akslen, L. A., Mœnstad, S. E., Larsen, B., Straume, Î., and Îgreid, D. Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. Int. J. Cancer, 79: 91-95, 1998.
12. Albino, A. P., Vidal, M. J., McNutt, N. S., Shea, C. R., Prieto, V. G., Nanus, D. M., Palmer, J. M., and Hayward, N. K. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res., 4: 35-45, 1994.
13. Bae, I., Smith, M. L., Sheikh, M. S., Zhan, Q., Scudiero, D. A., Friend, S. H., O'Connor, P. M., and Fornace, A. J., Jr. An abnormality in the p53 pathway following γ-radiation in many wild-type p53 human melanoma cell lines. Cancer Res., 56: 840-847, 1996.
14. Weiss, J., Heine, M., Arden, K. C., Korner, B., Pilch, H., Herbst, R. A., and Jung, E. G. Mutation and expression of TP53 in malignant melanomas. Recent Results Cancer Res., 139: 137-154, 1995.
15. Beroud, C., and Soussi, T. p53 gene mutation: software and database. Nucleic Acids Res., 26: 200-204, 1998.
16. Levin, D. B., Wilson, K., Valadares de Amorim, G., Webber, J., Kenny, P., and Kusser, W. Detection of p53 mutations in benign and dysplastic nevi. Cancer Res., 55: 4278-4282, 1995.
17. Lee, J. Y., Dong, S. M., Shin, M. S., Kim, S. Y., Lee, S. H., Kang, S. J., Lee, J. D., Kim, C. S., Kim, S. H., and Yoo, N. J. Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus. Biochem. Biophys. Res. Commun., 237: 667-672, 1997.
18. Samsher, M., and Montano, X. Analysis of intron 4 of the p53 gene in human cutaneous melanoma. Gene (Amst.), 176: 259-262, 1996.
19. Lassam, N. J., From, L., and Kahn, H. J. Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res., 53: 2235-2238, 1993.
20. McGregor, J. M., Yu, C. C., Dublin, E. A., Barnes, D. M., Levison, D. A., and MacDonald, D. M. p53 immunoreactivity in human malignant melanoma and dysplastic nevi. Br. J. Dermatol., 128: 606-611, 1993.
21. Flœrens, V. A., Holm, R., and Fœdstad, [/oe]. Accumulation of p53 protein in human malignant melanoma. Melanoma Res., 5: 183-187, 1995.
22. Fritsche, M., Haessler, C., and Brandner, G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8: 307-318, 1993.
23. Lu, X., and Lane, D. P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell, 75: 765-778, 1993.
24. Maltzman, W., and Czyzyk, L. UV irradiation stimulate levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol., 4: 1689-1694, 1984.
25. Hall, P. A., McKee, P. H., Menage, H. D., Dover, R., and Lane, D. P. High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8: 203-207, 1993.
26. Zhan, Q., Carrier, F., and Fornace, A. J. J. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol., 13: 4242-4250, 1993.
27. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. MDM2 promotes rapid degradation of p53. Nature (Lond.), 387: 296-299, 1997.
28. Kubbutat, M. H. G., Jones, S. N., and Vousden, K. H. Regulation of p53 stability by MDM2. Nature (Lond.), 387: 299-303, 1997.
29. Landers, J. E., Cassel, S. L., and George, D. L. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. Cancer Res., 57: 3562-3568, 1997.
30. Haapajärvi, T., Kivinen, L., Pitkänen, K., and Laiho, M. Cell cycle dependent effects of UV-radiation on p53 expression and retinoblastoma protein phosphorylation. Oncogene, 11: 151-159, 1995.
31. Haapajärvi, T., Pitkänen, K., Tsubari, M., and Laiho, M. p53 transactivation and protein accumulation are independently regulated by UV light in different phases of the cell cycle. Mol. Cell. Biol., 17: 3074-3080, 1997.
32. Wu, L., and Levine, A. Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene. Mol. Med., 3: 441-451, 1997.
33. Hupp, T. R., Sparks, A., and Lane, D. P. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell, 83: 237-249, 1995.
34. Lutzker, S., and Levine, A. J. A functionally inactive p53 protein in embryonal carcinoma cells is activated by DNA damage or cellular differentiation. Nat. Med., 2: 804-810, 1996.
35. Ko, L. J., and Prives, C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
36. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
37. Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev., 12: 2984-2991, 1998.
38. Jayamaran, L., Moorthy, N. C., Murthy, K. G. K., Manley, J. L., Bustin, M., and Prives, C. High mobility group protein-1 (HMG-1) ia a unique activator of p53. Genes Dev., 12: 462-472, 1998.
39. Jayamaran, L., Murthy, K. G. K., Zhu, C., Curran, T., Xanthoudakis, S., and Prives, C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev., 11: 558-570, 1997.
40. 1 arrest in UV-irradiated skin fibroblasts. Cancer Res., 57: 3390-3394, 1997.
41. Cip1. Oncogene, 11: 1675-1683, 1995.
42. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
43. Cordon-Cardo, C., Latres, E., Drobnjak, M., Oliva, M. R., Pollack, D., Woodruff, J. M., Marechal, V., Chen, J., Brennan, M. F., and Levine, A. J. Molecular abnormalities of mdm2 and p53 genes in soft tissue sarcomas. Cancer Res., 54: 794-799, 1994.
44. Lianes, P., Orlow, I., Zhang, Z-F., Oliva, M. R., Sarkis, A. S., Reuter, V. E., and Cordon-Cardo, C. Altered patterns of MDM2 and TP53 expression in human bladder cancer. J. Natl. Cancer Inst., 86: 1325-1330, 1994.
45. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
46. Fornace, A. J., Jr., Alamo, I., and Hollander, M. C. DNA damage-inducible transcripts in mammalian cells. Proc. Natl. Acad. Sci. USA, 85: 8800-8804, 1988.
47. Andrews, N. C., and Faller, D. V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res., 19: 2499, 1991.
48. Pitkänen, K., Haapajärvi, T., and Laiho, M. UVC-induction of p53 activation and accumulation is dependent on cell cycle and pathways involving protein synthesis and phosphorylation. Oncogene, 16: 459-469, 1998.
49. Montano, X., Shamsher, M., Whitehead, P., Dawson, K., and Newton, J. Analysis of p53 in human cutaneous melanoma cell lines. Oncogene, 9: 1455-1459, 1994.